Sellmann C Schulz

Medical School - Twin Cities Campus, Psychiatry

• Home
• Expert Overview
• Profile
• Publications
• Grants
• Similar Experts
• Journals
• Trends
• Institutional Network
• Coauthor Network
• Research Network

Sellmann C Schulz

• Organizations
  Medical School - Twin Cities Campus
  
  Psychiatry
  
  

  Current Appointments:

  Professor; Head (With Faculty Rank)

  
  
  

612/273-9820

Help us refine your profile

Manage your Funding

16 Grants

This is a chronological listing of grants held by this researcher, with the most recent listed first. This list contains only grants that were active as of July 1, 2008, or awarded since that date. New grants appear in this list periodically and contribute to the researcher's fingerprint profile. The source of grants for this application comes directly from your institution.

• 1.

  Kathryn Cullen; Lynn Eberly; Bonnie Klimes-Dougan; Kelvin Lim; Sellmann Schulz; Kathleen Thomas

  Exploring the Neural Circurity of Deliberate Self Harm in Adolescents

  4/19/2012 - 1/31/2014

  Sponsor: NIH Nat'l Institute of Mental Health

• 2.

  Sellmann Schulz

  International Congress on Schizophrenia Research

  3/1/2012 - 2/28/2017

  Sponsor: National Institutes of Health (NIH)

• 3.

  Sellmann Schulz; Sanjiv Kumra

  A Long-Term Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole OPC 14597 as Maintenance Treatment in Adolescent Patients with Schizophrenia

  3/15/2011 - 9/14/2013

  Sponsor: Otsuka Pharmaceutical Dev. & Comm., Inc.

• 4.

  Sellmann Schulz; John Grabowski; Sanjiv Kumra; Kelvin Lim; Marc Mooney; Michael O'Sullivan; Stephen Olson

  Proteomic Diagnostic Test for Schizophrenia

  8/1/2010 - 8/31/2013

  Sponsor: Rules-Based Medicine, Inc

• 5.

  Sellmann Schulz

  Functional Imaging for Research and Schizophrenia Treatment (FIRST) Program (Schulz) - Glutamate

  4/1/2008 - 8/31/2009

  Sponsor: Mind Institute

• 6.

  Sellmann Schulz

  Functional Imaging for Research and Schizophrenia Treatment (FIRST) Program (Schulz) - MCIC

  4/1/2008 - 8/31/2009

  Sponsor: Mind Institute

• 7.

  Sellmann Schulz

  Seroquel XR for the management of Borderline Personality Disorders BPD

  9/1/2007 - 8/31/2012

  Sponsor: AstraZeneca

• 8.

  Judith Berman; Gunda Georg; Bojan Guzina; Bin He; Michael Koob; Robert Kratzke; Tucker LeBien; Michael Levitt; Kelvin Lim; R Mc Ivor; Sang-Hyun Oh; Douglas Ohlendorf; Rajesh Rajamani; Sellmann Schulz; Arne Slungaard; James St. Louis; Robert Tranquillo; Masato Yamamoto

  Minnesota Partnership for Biotechnology and Medical Genomics Phase IV

  7/1/2007 - 12/31/2015

  Sponsor: ST OF MN

• 9.

  Sellmann Schulz

  Susie Poole-Minnesota

  7/1/2007 - 8/31/2009

  Sponsor: Mind Institute

• 10.

  Sellmann Schulz

  First-Glutamate

  7/1/2007 - 3/31/2008

  Sponsor: Mind Institute

• 11.

  Sellmann Schulz

  MIND - MCIC

  7/1/2007 - 3/31/2008

  Sponsor: Mind Institute

• 12.

  Sellmann Schulz

  Predicting response to Risperidone treatment through identification of early-onset of antipsychotic drug action in Schizophrenia

  6/1/2006 - 12/31/2007

  Sponsor: LILLY RES LAB

• 13.

  Sellmann Schulz

  MIND Study

  1/1/2006 - 12/31/2006

  Sponsor: Mind Institute

• 14.

  Sellmann Schulz

  Brain Correlates of Olanzapine Treatment Response in BPD

  8/26/2005 - 6/30/2010

  Sponsor: Eli Lilly and Company

• 15.

  Sellmann Schulz

  International Congress on Schizophrenia Research

  12/1/2002 - 11/30/2007

  Sponsor: NIH Nat'l Institute of Mental Health

• 16.

  Sellmann Schulz

  Quetiapine Safety and Efficacy in Patients With Borderline Personality Disorder

  7/8/2002 - 6/30/2007

  Sponsor: AstraZeneca